News

NIIMBL Lab
NIIMBL
Biomanufacturing, Biopharmaceutical
NIIMBL and FDA Sign Agreement to Support Innovation in Biopharma Manufacturing

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a Manufacturing USA institute, announced that the University of Delaware, on behalf of NIIMBL, has entered into a Collaborative Research and Development Agreement (CRADA) with the Food and Drug Administration (FDA). Effective July 15, 2019, the FDA and NIIMBL will...

NIIMBL Institute
NIIMBL
Bioengineering, Biomanufacturing, Biopharmaceutical
New Biopharmaceutical Manufacturing Projects (NIIMBL: Project Call 3.1)

The mission of the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a Manufacturing USA institute, is to accelerate biopharmaceutical manufacturing innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical...

awardees of the #NIIMBLeXperience.
NIIMBL
Biopharmaceutical, Health, Innovation
NSBE and NIIMBL Announce Student Awardees for Biopharma eXperience

NEWARK, Del. & ALEXANDRIA, Va., April 18, 2019 - The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) in partnership with the Healthcare Innovation Special Interest Group (HISIG) of the National Society of Black Engineers (NSBE) are pleased to announce the selection of seven students for the inaugural NIIMBL eXperience...

External News

SME
Biomanufacturing, Biopharmaceutical
Data-Driven Manufacturing

In my capacity as the Chair of the Council of the Manufacturing USA institute directors, I often get asked about trends in U.S. advanced manufacturing. When I receive a question like this, I try to think about advanced manufacturing as broadly as possible — and consider technologies that could stand to benefit most manufacturers, as well as the U.S...

Pharma Manufacturing
Biopharmaceutical, Education, Workforce
The Elephant in the Biopharma Classroom

The world can’t stop talking about biopharma’s scientific achievements, but the discussion often avoids the industry’s biggest potential buzzkill: a shortage of properly trained workers to manufacture these new drugs.

There’s no denying that biopharma drugs will play a vital role in the future of medicine. Biologics make up about 40 percent of the...

Our Network @ Work